Today: 29 April 2026
Ares Management stock drops 3% in New York as Fed minutes hit year-end trading
30 December 2025
2 mins read

Ares Management stock drops 3% in New York as Fed minutes hit year-end trading

NEW YORK, December 30, 2025, 2:20 PM ET — Regular session

  • Ares Management shares fell about 3% in afternoon trade, underperforming major listed alternative-asset peers.
  • Investors digested fresh Federal Reserve minutes that highlighted divisions over the path for rate cuts.
  • A Reuters Breakingviews column flagged shrinking yield advantages in private credit, a key business line for Ares.

Shares of Ares Management Corp fell 3.1% to $163.85 in afternoon trading on Tuesday, down $5.20 from Monday’s close. The stock traded between $168.99 and $163.49, with about 966,000 shares changing hands.

The move matters because Ares is closely tied to credit-market conditions. Investors are weighing where interest rates settle in early 2026 and what that means for fundraising, deal activity and returns in private credit.

A Reuters Breakingviews column said private credit is losing some of its pricing edge as bank-led bond and loan markets regain momentum, pushing terms closer together. It also said the yield premium — the extra return private loans offer over comparable public-market debt — has narrowed, a dynamic that can pressure returns across the roughly $2 trillion private credit market.

Fresh Federal Reserve minutes released Tuesday showed policymakers were split at the December 9–10 meeting, with some officials calling the decision to cut rates “finely balanced.” The quarter-point cut lowered the benchmark rate to a 3.5%–3.75% range, and the minutes pointed to debate over how long to hold rates steady as inflation progress has been uneven; the Fed’s next meeting is Jan. 27–28, with key U.S. jobs and inflation reports due Jan. 9 and Jan. 13. Reuters

U.S. stocks were muted in thin, holiday-truncated trade, with declines in financials offsetting strength elsewhere. “It’s just a healthy rebalancing of allocations more so than an emotionally driven sell-off,” said Mark Hackett, chief market strategist at Nationwide. Reuters

Ares’ drop stood out against other big listed alternative-asset managers, which were little changed to modestly lower: Blackstone was flat, while Apollo, KKR and Carlyle were down around half a percent or less.

Private credit refers to loans made outside public bond and syndicated loan markets, often directly to companies, typically with fewer intermediaries. Investors focus on the “spread,” or extra compensation, because it helps determine whether private loans still pay enough to justify their lower liquidity.

A narrower premium tends to squeeze returns unless managers can protect deal terms, lower funding costs or move into higher-margin strategies. For Ares, that puts a premium on maintaining asset growth and performance as competition increases.

Rate expectations add another layer. Lower policy rates can boost refinancing and deal activity, but they also reduce coupons on many floating-rate loans, which can dampen income unless credit spreads widen or leverage rises.

Traders will also watch whether the Fed’s internal divisions translate into a longer pause on cuts, which can keep borrowing costs elevated and affect valuations for credit-heavy assets. The tone of January’s data releases will be a key near-term driver for rate-sensitive financial stocks.

In the near term, investors will be looking for signs that private credit can hold pricing power as banks compete more aggressively for deals. They will also be monitoring fund flows into private-market products and any read-through from credit issuance into fee growth expectations for asset managers.

Stock Market Today

  • Align Technology Beats Q1 Sales Estimates, Reports $1.04 Billion Revenue
    April 29, 2026, 4:41 PM EDT. Align Technology (NASDAQ:ALGN) reported a strong Q1 CY2026 with 6.2% year-on-year sales growth to $1.04 billion, exceeding Wall Street revenue estimates by 1.8%. Adjusted earnings per share came in at $2.58, 12.8% above analyst consensus. The company's operating income also beat expectations by 11.1%, driven by solid operating margins of 21.5%. Despite these gains, Align projected next quarter revenue around $1.05 billion, aligning with market forecasts. The company's five-year annualized revenue growth of 7.8% outpaces healthcare sector averages, but recent two-year growth has slowed to 2.3%, raising concerns about demand trends. Analysts project modest growth going forward, around 3%, indicating cautious investor sentiment on new product impact.

Latest article

Nebius Stock Jumps as Meta’s AI Spending Reset Puts $27 Billion Deal in Focus

Nebius Stock Jumps as Meta’s AI Spending Reset Puts $27 Billion Deal in Focus

29 April 2026
Nebius Group N.V. shares rose 5.3% to $142.73 Wednesday as Meta Platforms raised its 2026 capital spending forecast by up to $10 billion, citing higher data center costs. Nebius has a contract to supply Meta with up to $27 billion in AI cloud capacity. Fourth-quarter 2025 revenue jumped 547% to $227.7 million, but the company reported a net loss of $249.6 million.
Phillips 66 Stock Jumps as Surprise Profit Shows Refining Margins Are Back in Focus

Phillips 66 Stock Jumps as Surprise Profit Shows Refining Margins Are Back in Focus

29 April 2026
Phillips 66 reported an adjusted first-quarter profit of $200 million, or 49 cents per share, beating analyst forecasts of a loss. Strong refining margins and 95% plant utilization offset $839 million in hedge-related losses. Shares rose over 6% after the results. The company also completed its acquisition of Lindsey Oil Refinery assets in the UK.
Extreme Networks Stock Jumps as Q3 Earnings Beat Puts Cisco, HPE Rivals in Focus

Extreme Networks Stock Jumps as Q3 Earnings Beat Puts Cisco, HPE Rivals in Focus

29 April 2026
Extreme Networks shares surged 28% after reporting fiscal Q3 revenue of $316.9 million, up 11%, and non-GAAP earnings of 26 cents per share, both above estimates. The company forecast Q4 revenue of $330–$335 million, topping FactSet’s $326.9 million estimate. SaaS annual recurring revenue rose 28.6% to $236.4 million. Net income climbed to $10.6 million from $3.5 million a year earlier.
Soleno Therapeutics stock slides today: SLNO drops on investor-alert headline as biotech sector slips
Previous Story

Soleno Therapeutics stock slides today: SLNO drops on investor-alert headline as biotech sector slips

Meta stock closes up on Manus AI agent deal — what investors are watching next
Next Story

Meta stock closes up on Manus AI agent deal — what investors are watching next

Go toTop